To this end, we measure changes in biomarkers for factor Xa-dependent (factor Xa activity) and independent pathways (cfDNAs, a marker of NETosis), and compared the effects of DOACs and LMWHs on D-dimer levels, a marker of coagulopathy. Here, F10 is linked to blood coagulation disease.